Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PSMA Expression in Triple Negative Breast Cancer Patients Using 18 F-DCFPyL-PET/CT

NCT06586047 is registered in ClinicalTrials.gov with Ahmad Shariftabrizi as lead sponsor.

NCT NCT06586047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06586047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PSMA Expression in Triple Negative Breast Cancer Patients Using 18 F-DCFPyL-PET/CT
Lead sponsor
Ahmad Shariftabrizi
Phase
Phase 1
Overall status
Recruiting
Start date
August 29, 2024
Completion date
September 1, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer